Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT

NCT03283566 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Chronic Pancreatitis
Insulin Dependent Diabetes

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo

Sponsor

The Cleveland Clinic

Collaborators

[object Object]
[object Object]